# Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer

> **NCT04311762** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Vermont** · enrollment: 16 (estimated)

## Conditions studied

- Lung Cancer Metastatic

## Interventions

- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT04311762
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-02-01
- **Primary completion:** 2029-03-01
- **Final completion:** 2029-03-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04311762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04311762, "Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04311762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*